For these reasons, we were led to study the association between the immunoreactivity of the tumor markers TS, p53, COX2, EGFR, MSH6 and MLH1 in cases of colorectal cancer and the main clinical and pathological prognostic factors. The gene discussed is PTGS2; the disease is colorectal cancer.